NMR spectroscopy laboratory for pharmaceutical impurity level confirmation
CMC Strategy

Impurity Level Confirmation by Nuclear Magnetic Resonance (NMR) Spectroscopy

Almac Group
CMC Strategy

Two approaches for determining known process impurity levels in multiple batches of API.

This case study discusses two approaches taken when clients required determination of known process impurities in multiple API batches, addressing technical challenges in impurity detection.

This case study discusses two approaches taken when clients required determination of known process impurities in multiple API batches, addressing technical challenges in impurity detection.

Why NMR

NMR provides structural information and quantification without requiring reference standards for every impurity.

Two Approaches

Differing client needs led to complementary strategies for batch analysis.

Technical Challenges

Signal overlap and sensitivity were managed through careful method design.

Download This White Paper

Biotechnology Media Insights

Continue to Biotechnology Media Insights to access this white paper.

Pharmaceutical & Biotechnology White Papers | Biotechnology Media Insights